Locally Advanced Solid Tumor research hub
3 indexed studies · 3 currently recruiting
- recruitingPHASE2
CD8 PET Imaging in Metastatic Solid Tumours
This study looks at a new type of specialised scan for people with advanced cancer. It uses a small amount of a special substance called 89Zr-Df-crefmirlimab to create detailed pictures. This helps doctors see how well a new cancer treatment, called PD-1 antibody therapy, is working.
Netherlands · Spain · United Kingdom - recruitingPHASE1, PHASE2
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
This study is testing a new drug, neladalkib, for advanced cancers that have a specific genetic change called ALK rearrangement. It's looking at how safe the drug is and if it shrinks tumours in people with certain types of lung cancer and other solid tumours.
United States · Australia · Belgium - recruitingPHASE1, PHASE2
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
This study is testing a new drug, zidesamtinib, for people with advanced cancer that has a specific genetic change called a ROS1 rearrangement. It will check how safe the drug is and if it can shrink tumours.
United States · Australia · Belgium